GLP-1 RA and atrial fibrillation in the cardiovascular outcome trials

Diabetes Metab Res Rev. 2021 Jul;37(5):e3436. doi: 10.1002/dmrr.3436. Epub 2021 Feb 2.

Authors

Zahra Hamedi¹, Basem M Mishriky¹, Victor Okunrintemi¹, James R Powell¹, Doyle M Cummings²

Affiliations

¹ Department of Internal Medicine, East Carolina University, Greenville, North Carolina, USA.
² Department of Family Medicine, East Carolina University, Greenville, North Carolina, USA.

PMID: 33440044
DOI: 10.1002/dmrr.3436

No abstract available

Keywords: GLP-1 RA; atrial fibrillation; cardiovascular outcome trials; meta-analysis; type 2 diabetes.

MeSH terms

Atrial Fibrillation* / epidemiology
Cardiovascular System*
Diabetes Mellitus, Type 2
Glucagon-Like Peptide 1
Glucagon-Like Peptide-1 Receptor
Humans
Hypoglycemic Agents

Substances

Glucagon-Like Peptide-1 Receptor
Hypoglycemic Agents
Glucagon-Like Peptide 1